Lead Product(s) : Contezolid Acefosamil
Therapeutic Area : Podiatry
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
MicuRx: Contezolid Phase III Trial Endorsed, Promising for Diabetic Foot Infection
Details : MRX-4 (contezolid acefosamil) is being evaluating in the late-stage clinical trials studies for the treatment of patients suffering from Diabetic Foot Infection.
Product Name : MRX-4
Product Type : Antibiotic
Upfront Cash : Inapplicable
February 25, 2025
Lead Product(s) : Contezolid Acefosamil
Therapeutic Area : Podiatry
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
